click on circles to display study description...
Janssen AD26 vaccine (JNJ-78436735) (n=21895) vs. placebo (n=21888)
randomized controlled trial
Janssen Ad26.COV2.S vaccine single dose (5x1010 vp) intramuscular
placebo
COVID-19 prophylaxis (excluding children)
double blind
Argentina, Brazil, Chile, Colombia, Mexico, Peru, South Africa, and the United States
powered by vis.js Network
An extraction panel is open